-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.P1.39 632. Chronic Myeloid Leukemia: Therapy: Poster I Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, Biological, Coronaviruses, Leukemia, SARS-CoV-2/COVID-19, CML, Diseases, Non-Biological, CMML, Elderly, Therapies, Adverse Events, chemotherapy, enzyme inhibitors, Technology and Procedures, Young Adult, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, pharmacology, TKI, serologic tests
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Dennis Dong Hwan Kim, MD1, Igor Nicolas Novitzky-Basso, MD, PhD, MRCP, FRCPath2, Taehyung Kim, MSc3, Eshetu G Atenafu, M.Sc., P.Stat4*, Donna L. Forrest, MD5, Lynn Savoie, MD6*, Isabelle Bence-Bruckler, MD7*, Mary-Margaret Keating, MD, FRCPC8, Lambert Busque, MD9, Robert Delage, MD10, Anargyros Xenocostas, MD, FRCPC11, Elena Liew, MD, BSc, FRCPC12, Kristjan Paulson, MD13, Tracy L. Stockley, PhD, FCCMG, FACMG14*, Pierre Laneuville, MD, FRCPC15, Jeffrey H. Lipton, MD, PhD16, Suzanne Kamel-Reid, BA, MA, PhD, FACMG17 and Brian Leber, MD18

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
3Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
4Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Leukemia/BMT Program of British Columbia, Division of Hematology, Vancouver General Hospital, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada
6University of Calgary, Alberta Health Services, Calgary, AB, Canada
7Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
8Hematology/Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
9Hematopoiesis and Aging Research Unit, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
10CHU de Québec, Hôpital de l'Enfant-Jésus, Centre Universitaire d'Hématologie et d'Oncologie de Québec, Quebec City, QC, Canada
11Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada
12University of Alberta Hospital, Edmonton, AB, Canada
13Cancercare Manitoba, Winnipeg, MB, Canada
14Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada
15Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
16Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
17Advanced Molecular Diagnostics Laboratory, University of Toronto, University Health Network, Toronto, ON, Canada
18Division of Hematology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada

Massimiliano Bonifacio, MD1*, Gianni Binotto, MD2*, Mario Tiribelli, MD3*, Maria Cristina Miggiano, MD4*, Malgorzata Monika Trawinska, MD5*, Luigi Scaffidi, MD1*, Eros Di Bona, MD4*, Daniela Damiani, MD3*, Vanessa Velotta6*, Giulia Ceccarelli6*, Elisabetta Pierdomenico, MD2*, Mariella Loschirico, MD2*, Maria Vittoria Dubbini, MD3*, Maddalena Cordioli, MD7*, Marco Ruggeri, MD4, Renato Fanin, MD3*, Gianpietro Semenzato, MD2*, Evelina Tacconelli, MD7*, Giovanni Pizzolo, MD1 and Mauro Krampera, MD, PhD1

1Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
2Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
3Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
4Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
5ASL Roma2, Department of Hematology S. Eugenio Hospital, Rome, Italy, Rome, Italy
6ASL Roma2, Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy
7Department of Diagnostics and Public Health, Section of Infectious Diseases, University of Verona, Verona, Italy

Koji Sasaki, MD1, Hagop M. Kantarjian, MD2, Ghayas C. Issa, MD1, Guillermo Garcia-Manero, MD1, Tapan M. Kadia, MD3, William G. Wierda, MD, PhD1, Musa Yilmaz, MD1, Courtney D. DiNardo, MD, MSc4, Jeffrey Skinner, MHA1*, Rita Khouri1*, Naveen Pemmaraju, MD1, Patrice Nasnas, MD1*, Sara E Dellasala, BS5*, Sherry A. Pierce, BSN, BA1*, Jorge E. Cortes, MD6 and Elias Jabbour, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
6Georgia Cancer Center Augusta University, Augusta, GA

Franck E Nicolini, MD, PhD1,2, Vincent Alcazer, MD1,2*, Pascale Cony-Makhoul, MD1,3*, Stephanie Dulucq, PharmD, PhD1,4*, Sandrine Hayette, PhD1,5*, Stephane Morisset, BioStat2*, Jean-Michel Cayuela, PharmD, PhD1,6*, Marie-Pierre Fort, PhD7*, Christophe Bouvier, CRA1,2*, Clemence Deteix-Santana, MD2*, Etienne Lengline, MD8*, Delphine Rea, MD, PhD1,9, Francois-Xavier Mahon, MD, PhD1,7 and Gabriel Etienne, MD, PhD1,7*

1Fi-LMC group, Pessac, France
2Hematology, Centre Leon Berard, Lyon, France
3Service d'Hématologie, Centre Hospitalier Annecy-Genevois, Pringy, France
4Laboratory of Hematology, University Hospital of Bordeaux, Hôpital Haut Lévêque, Pessac, France
5Centre Hospitalier Lyon Sud, Pierre Benite, FRA
6Laboratory of Hematology, University Hospital Saint-Louis, Paris, France
7Hematology Department, Institut Bergonié, Bordeaux, France
8Hematology Department, Saint-Louis Hospital AP-HP Paris France, Paris, France
9Hematology department, Hopital Saint Louis, Paris, France

Gabriele Gugliotta, MD, PhD1, Mario Annunziata, MD2*, Isabella Capodanno, MD3*, Davide Rapezzi, MD4*, Immacolata Attolico, MD5*, Iolanda Donatella Vincelli6*, Mario Tiribelli, MD7*, Alessandra Malato, MD, PhD8*, Michele Pizzuti, MD9*, Vincenzo Accurso, MD10*, Massimiliano Bonifacio, MD11*, Sara Galimberti, MD, PhD12*, Giuseppina Loglisci, MD13*, Elisabetta Abruzzese, MD 14, Monica Bocchia15*, Antonella Gozzini, MD16*, Micaela Bergamaschi, MD17*, Maria Cristina Miggiano, MD18*, Agostino Tafuri, MD19, Grazia Sanpaolo, MD20*, Gianni Binotto, MD21*, Fausto Castagnetti, MD, PhD1, Giorgina Specchia, MD22, Francesco Di Raimondo, MD23, Michele Cavo1*, Gianantonio Rosti, MD1*, Robin Foà, MD24, Giuseppe Saglio, MD, PhD25, Massimo Breccia, MD26* and Fabio Stagno, MD, PhD23

1"Seràgnoli" Institute of Hematology, Sant'Orsola-Malpighi University Hospital, Bologna, Italy
2Hematology Unit, Cardarelli Hospital, Naples, Italy
3Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
4S.C. Ematologia, ASO S. Croce e Carle, Cuneo, Italy
5Hematology and Stem cell Transplantation Unit - Department of Emergency and Organ Transplantation (D.E.T.O.) - University of Bari, Bari, Italy
6UOC Ematologia Grande Ospedale Metropolitano BMM, Reggio Calabria, Italy
7Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
8Department of Hematology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
9Ematologia, Azieda Ospedaliera S. Carlo, Potenza, Italy
10U O di Ematologia Divisione di Oncologia, Az Osp Univ Policlinico P Giaccone Universita Studi Palermo, Palermo, Italy
11Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
12Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
13Hematology Unit, Vito Fazzi Hospital, Lecce, Italy
14Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Tor Vergata University, Rome Italy, Rome, Italy
15Hematology, University of Siena, Siena, Italy
16Hematology Unit, AOU Careggi, University of Florence, Florence, ITA
17Hematology Clinic, Policlinico S.Martino-IRCCS, Genova, Italy
18Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
19Hematology Unit, University Hospital Sant'Andrea-Sapienza, Rome, ITA
20Division of Hematology, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
21Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
22Hematology Section, Department of Emergency and Transplantation - GIMEMA WP CML, University of Bari Aldo Moro, Bari, Italy
23Division of Hematology, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy
24Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy
25Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy
26Department of Translational and Precision Medicine, Sapienza University, Rome, Italy

Kiyomi Morita, MD, PhD1, Hagop M. Kantarjian, MD1, Farhad Ravandi, MBBS1, Koji Sasaki, MD1, Nitin Jain, MD1, Marina Konopleva, MD, PhD1, Nicholas J. Short, MD1, Koichi Takahashi, MD, PhD1, Rita Khouri1*, Patrice Nasnas, MD1*, Courtney D. DiNardo, MD, MSc1, Tapan M. Kadia, MD1, Guillermo Garcia-Manero, MD1, Naval Daver, MD1, Guillermo Montalban Bravo, MD1, Ghayas C. Issa, MD1, Jorge E. Cortes, MD2 and Elias Jabbour, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Georgia Cancer Center, Augusta University, Augusta, GA

Katia B Pagnano, MD, PhD1, Ana Carolina Mourão Toreli, MD2*, Leila Martins Perobelli, MD2*, Acy TS Quixada, MD3*, Fernanda S Seguro, MD4,5*, Israel Bendit, MD, PhD6*, Marcia Torresan Delamain, MD, PhD1*, Jaqueline Sapelli, MD7*, Muriel Silva Moura, MD8*, Jaisson Bortolini, MD9,10*, André LG Lourenço, MD11*, Natália N Gonçalves, MD12*, Monika Conchon, MD12*, Fabio Moore Nucci, MD, PhD13*, Luciene Da Cruz Oliveira, MD14*, Gustavo HR Magalhães, MD; MSc15*, Vaneuza Funke, MD16*, Renato Tavares, MD17*, Renato Torrescasana Centrone, MD18*, Fabio PS Santos, MD, PhD19, Laura Fogliatto, MD, PhD20, Leonardo Carvalho Palma, MD21, Nelma D Clementino, MD22*, Paula OM Hokama, MD, PhD23* and Carla M Boquimpani, MD24*

1Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
2Hospital de Transplantes Euryclides de Jesus Zerbini, São Paulo, Brazil
3Hospital Universitário Walter Cantídio - Universidade Federal do Ceara, Fortaleza, Brazil
4Hematology Department, Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil
5Hospital das Clinicas da Faculdade de Medicina - Hematology Department, Universidade de Sao Paulo, Sao Paulo, Brazil
6Division of Hematology, Hospital das Clínicas da Faculdade de Medicina (HCFMUSP), University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil
7AC Camargo Cancer Center, São Paulo, Brazil
8Hospital Santa Casa de Misericordia de Maceió, Maceio, Brazil
9Centro de Pesquisas Oncologicas, Florianopolis, Brazil
10SOMA - Clinica de Oncologia, Florianopolis, Brazil
11Hospital Fornecedores de Cana de Piracicaba, Piracicaba, Brazil
12Hospital Santa Marcelina, São Paulo, Brazil
13Hospital Universitário Antônio Pedro, RIO DE JANEIRO, Brazil
14Hospital Jorge Valente, Salvador, Brazil
15Hematology Unit - Hospital das Clínicas - Minas Gerais Federal University, Belo Horizonte, Brazil
16Complexo Hospital de Clínicas - Universidade Federal do Paraná, Curitiba, Brazil
17Hospital das Clinicas, Universidade Federal de Goiania, Goiás, Brazil
18Instituto Hemomed, Sao Paulo, SP, Brazil
19Hospital Israelita Albert Einstein, Sao Paulo, SP, AC, Brazil
20Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
21Department of Medical Images, Hematology and Clinical Oncology, Hematology division, Ribeirão Preto, AC, Brazil
22Grupo Oncoclinicas, Belo Horizonte, Brazil
23São Paulo State University, Botucatu, Brazil
24HEMORIO, Rio De Janeiro, Brazil

Alejandro Luna, MD1*, Natalia Estrada2*, Concepcion Boque, MD. PhD3*, Blanca Xicoy, MD4*, Pilar Giraldo, PhD5, Anna Angona6*, Alberto Alvarez-Larrán, MD, PhD7*, Fermin Sanchez-Guijo, MD, PhD8*, María José Ramírez9*, Juan M. Alonso-Domínguez10*, Elvira Mora11*, Patricia Vélez, MD12*, Ana Rosell13*, Mercedes Colorado Araujo14*, Beatriz Cuevas, MD15*, Miguel Sagüés3*, Montserrat Cortes16*, Manuel Perez Encinas, MD17*, Luis Felipe Casado Montero, MD18, Melania Moreno Vega19*, Luis Serrano20*, Valle Gomez21*, Carmen Garcia-Hernandez, MD22*, Sunil Lakhwani Lakhwani23*, Antonio Paz Coll24*, Raquel de Paz, MD25*, Sara Suarez-Varela26*, Andrés Fernandez-Ruiz3*, Raul Perez Lopez27*, Almudena Ortiz-Fernández28*, Antonio Jiménez-Velasco, MD29* and Valentín Garcia-Gutiérrez, MD, PhD1

1Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
2Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona, Spain
3Institut Catala d'Oncologia - L'Hospitalet de Llobregat, L'Hospitalet de Llobregat, Spain
4Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol; Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain
5Hospital Quiron Zaragoza, Zaragoza, Spain
6Hematology, Institut Català d'Oncologia - Girona, Girona, Spain
7Hematology Department, Hospital Clínic, Barcelona, Spain
8Hematology Department, IBSAL-Hospital Universitario de Salamanca, CIC and CIBERONC, University of Salamanca, Salamanca, Spain
9Hematology Department, Hospital de Jerez de la Frontera, Jerez, Spain
10Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), UAM, Madrid, Spain
11Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
12Hospital Mutua Terrassa, Terrassa, Spain
13Hematology, Hospital Virgen de la Victoria, Malaga, Spain
14Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia, Santander, Spain
15Hematology, Hospital Universitario de Burgos, BURGOS, ESP
16Hospital General de Granollers, Barcelona, Spain
17Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
18Hospital Virgen de la Salud, Toledo, Madrid, Spain
19Hospital Doctor José Molina Orosa de Lanzarote, Arrecife, Spain
20Hospital General de Castellón, Castellón, Spain
21Hospital Universitario La Princesa, Madrid, ESP
22Hospital General de Alicante, Alicante, Spain
23Department of Hematology, Hospital Universitario de Canarias, La Laguna, La Laguna, Spain
24Hospital Universitario Puerto Real, Puerto Real, ESP
25Hematology Department, Hospital Universitario La Paz-Idipaz, Madrid, Spain
26Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain
27Servicio de Hematología, Hospital Universitario Clínico Virgen de la Arrixaca, MURCIA, Spain
28Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain
29Hospital Universitario Carlos Haya, Malaga, Spain

Guillermo Montalban Bravo, MD1, Faezeh Darbaniyan, PhD2*, Rashmi Kanagal-Shamanna, MD3, Irene Ganan-Gomez, PhD1, Koji Sasaki, MD4, Kiran Naqvi, MD, MPH4, Yue Wei, PhD1, Hui Yang, MD, PhD1, Kelly A. Soltysiak, PhD4*, Kelly S. Chien, MD1, Carlos E. Bueso-Ramos, MD, PhD3, Hagop M. Kantarjian, MD1 and Guillermo Garcia-Manero, MD4

1Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Sung-Eun Lee, M.D, Ph.D.1*, Joon Seong Park, MD2*, Young Rok Do, PhD, MD3, Sung-Hyun Kim, MD, PhD4, Dae Young Zang, MD, PhD5*, Sukjoong Oh, MD, PhD6, Jae-Yong Kwak7, Jeong-A Kim8, Yeung-Chul Mun, MD9*, Won Sik Lee, MD, PhD10 and Dong-Wook Kim, MD1,11

1Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Ajou University School of Medicine, Suwon, Korea, Republic of (South)
3Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea, Republic of (South)
4Dong-A University College of Medicine, Busan, Korea, Republic of (South)
5Hallym University College of Medicine, Anyang, Korea, Republic of (South)
6Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, Seoul, Korea, Republic of (South)
7Chonbuk National University Medical School, Jeonju, Korea, Republic of (South)
8Department of Hematology, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Suwon, South Korea
9Department of Hematology, Ewha Womans University, Seoul, Korea, Republic of (South)
10Inje University College of Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
11Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Elzbieta Szczepanek, MD1*, Ositadima Chukwu1*, Magdalena Kaminska1*, Hubert Wysoglad1*, Agnieszka Cenda1*, Joanna Waclaw, MD1*, Magdalena Zawada, MD PhD2*, Magdalena Jakobczyk2* and Tomasz Sacha, MD PhD1*

1Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
2Department of Hematology Diagnostics, Jagiellonian University Medical College, Krakow, Poland

Christos Varelas, MD, MSc1*, Anastasia Athanasiadou, MD PhD1*, Eleni Gavriilaki, MD2, Maria Gkaitatzi1*, Georgios Papaioannou1*, Tasoula Touloumenidou2*, Chrysanthi Vadikoliou1*, Chrysavgi Lalayanni1*, Niki Stavroyianni1*, Lila Papalexandri, MD1*, Ioannis Batsis1*, Ioanna Sakellari, MD PhD2* and Achilles Anagnostopoulos2

1Hematology Department - HCT Unit, George Papanikolaou Hospital, Thessaloniki, Greece
2Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece

Frédéric Millot1*, Meinolf Suttorp2, Stéphanie Ragot1*, Guy Leverger, MD, PhD3*, Jean-Hugues Dalle, MD, PhD4*, Birgitta Versluijs5*, Birgitte Lausen6* and Marina Borisevich7*

1Inserm CIC 1402, University Hospital, Poitiers, France
2Pediatric Hemato-Oncology, Medical Faculty, Technical Univ. Dresden, Dresden, Germany
3Pediatric Hematology and Oncology Department, Hôpital Armand-Trousseau, Paris, France
4APHP, Robert Debré Hospital, Paris, France
5Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
6Rigshospitalet, National University Hospital, Copenhagen, DNK
7Belarusian Research Centre for Paediatric Oncology, Haematology and Immunology, Minsk, Belarus

Dennis Dong Hwan Kim, MD1, Igor Nicolas Novitzky-Basso, MD, PhD, MRCP, FRCPath2, Taehyung Kim, MSc3, Eshetu G Atenafu, M.Sc., P.Stat4*, Lynn Savoie, MD5*, Isabelle Bence-Bruckler, MD6*, Donna L. Forrest, MD7, Lambert Busque, MD8, Robert Delage, MD9, Anargyros Xenocostas, MD, FRCPC10, Mary-Margaret Keating, MD, FRCPC11, Elena Liew, MD, BSc, FRCPC12, Kristjan Paulson, MD13, Tracy L. Stockley, PhD, FCCMG, FACMG14*, Pierre Laneuville, MD, FRCPC15, Jeffrey H. Lipton, MD, PhD16, Suzanne Kamel-Reid, BA, MA, PhD, FACMG17 and Brian Leber, MD18

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
3Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
4Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5University of Calgary, Alberta Health Services, Calgary, AB, Canada
6Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
7Leukemia/BMT Program of British Columbia, Division of Hematology, Vancouver General Hospital, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada
8Hematopoiesis and Aging Research Unit, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
9CHU de Québec, Hôpital de l'Enfant-Jésus, Centre Universitaire d'Hématologie et d'Oncologie de Québec, Quebec City, QC, Canada
10Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada
11Hematology/Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
12University of Alberta Hospital, Edmonton, AB, Canada
13Cancercare Manitoba, Winnipeg, MB, Canada
14Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada
15Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
16Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON, Canada
17Advanced Molecular Diagnostics Laboratory, University of Toronto, University Health Network, Toronto, ON, Canada
18Division of Hematology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada

*signifies non-member of ASH